中化装备科技(青岛)股份有限公司 2024年度独立董事术职报告 (孙凌玉) 作为中化装备科技(青岛)股份有限公司(以下简称"公 司")的独立董事,2024年度,本人严格按照《公司法》《证 券法》《上海证券交易所股票上市规则》《上市公司治理准 则》《上市公司独立董事管理办法》《公司章程》《中化装 备科技(青岛)股份有限公司独立董事工作制度》等有关法 律法规以及公司制度规定,忠实勤勉履行职责,独立审慎行 使职权,积极出席相关会议,认真审议董事会各项议案,主 动了解公司经营情况,充分利用专业知识对公司重大事项发 表了客观、公正的意见,切实维护了公司和全体股东尤其是 中小股东的合法权益。 现将 2024 年度工作情况报告如下: 一、基本情况 (一)个人履历 本人孙凌玉,女,1966年11月出生,博士研究生。现 任北京航空航天大学交通科学与工程学院教授、博士生导师, 中国科协先进材料学会联合体专家委员会委员,中国汽车工 程学会轻量化联盟专家委员会委员,中国复合材料学会第七 届、八届理事,国际先进材料制造学会(SAMPE)大陆地区 理事,中国工程教育认证评审专家,公司第八届董事会独立 董事、薪酬与考核委员会主任委员(召集 ...

第五条 中化装备董事会审计委员会负责内部控制评价工作，监督内部控制 的有效实施和内部控制评价情况。 第一条 为进一步规范中化装备科技（青岛）股份有限公司（以下简称"中 化装备"或"公司"）内部控制评价工作，根据《企业内部控制基本规范》及其 配套指引、《关于加强中央企业内控体系建设与监督工作的实施意见》、《上海证 券交易所上市公司内部控制指引》等相关制度要求，制定本办法。 第二条 本办法所称内部控制评价，是指公司董事会审计委员会实施的、评 价内部控制的有效性并出具评价报告的过程。评价工作分为内控自评及监督评价 两种方式。 第三条 本办法适用于中化装备本部、中化装备履行出资人职责的全资子公 司、控股（含相对控股）子公司以及公司受托管理的企业（以下统称"各单位"）。 第二章 机构与职责 内部控制评价管理办法 目 录 第四条 公司实行统一领导、分级负责的内控评价工作机制。在公司各单位 全面开展年度内控自评工作的基础上，监督评价工作每三年覆盖全部子企业。 中化装备科技（青岛）股份有限公司 第一章 总则 第六条 中化装备内部控制评价工作的归口管理部门是审计部，各单位应指 定相关部门牵头负责本单位及下属企业的内控评价工作。 ...

中化装备科技（青岛）股份有限公司 外汇衍生品交易业务管理制度 （2025 年 4 月修订） 目 录 第一章 总则 第一条 为规范中化装备科技（青岛）股份有限公司（以下简称"公司"） 外汇衍生品交易业务及相关信息披露工作，加强对外汇衍生品交易业务的管理， 防范投资风险，健全和完善公司外汇衍生品交易业务管理机制，确保公司资产安 全，根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司信息披 露管理办法》《上海证券交易所股票上市规则》《上海证券交易所上市公司自律监 管指引第 5 号——交易与关联交易》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等相关法律、法规及规范性文件和《中化装备科技（青岛） 公司章程》（以下简称"公司章程"）等有关规定，结合公司实际情况制定本制度。 第二条 本制度所称外汇衍生品交易是指根据公司及合并报表范围内子公 司（以下简称"子公司"）国际业务的外币收支情况，在具有外汇衍生品交易业 务资质、经营稳健且资信良好的金融机构办理的规避和防范汇率或利率风险的外 1 第一章 总 则 第二章 外汇衍生品交易业务操作原则 第三章 外汇衍生品交易业务的审批权限 第四章 外汇衍生品交 ...

中化装备科技（青岛）股份有限公司内部审计管理规定 目 录 | 第一章 | 总 则 | | --- | --- | | 第二章 | 审计机构与人员 | | 第三章 | 审计职责 | | 第四章 | 审计权限 | | 第五章 | 审计程序 | | 第六章 | 罚 则 | | 第七章 | 附 则 | 第一章 总 则 第一条 为有效推动中化装备科技（青岛）股份有限公司（以下简称"中化 装备"或"公司"）构建集中统一、全面覆盖、权威高效的审计监督体系，提高 内部审计工作质量，充分发挥内部审计作用，保护投资者合法权益，根据《中华 人民共和国审计法》《审计署关于内部审计工作的规定》《关于深化中央企业内 部审计监督工作的实施意见》《上海证券交易所上市公司自律监管指引第 1 号— —规范运作》《中化装备科技（青岛）股份有限公司章程》以及《中化装备科技 （青岛）股份有限公司董事会议事规则》等相关规定，制定本规定。 第二条 中化装备内部审计包括监督与服务两大核心职能，围绕公司战略发 展和改革创新目标，通过独立、客观的确认、评价与建议，推动公司发展战略的 贯彻落实，促进企业合规运营和管理提升，为公司战略使命达成和高质量发展提 供有力 ...

第二条 委员会是董事会按照《公司章程》设立的专门工作机构，主要负 责研究董事与高级管理人员考核的标准，进行考核并提出建议；研究和审查董事、 高级管理人员的薪酬政策与方案。委员会对董事会负责。 第三条 本实施细则所称董事是指包括独立董事在内的由股东会选举产 生的全体董事；高级管理人员是指董事会聘任的总经理、副总经理、财务负责人、 董事会秘书、总法律顾问及《公司章程》规定的其他高级管理人员。 第四条 公司人力资源部为委员会的日常办事机构，负责提供公司有关人 1 第一章 总 则 第二章 人员组成 第三章 职责权限 第四章 决策程序 第五章 议事规则 第六章 附 则 中化装备科技（青岛）股份有限公司 董事会薪酬与考核委员会实施细则 目 录 第一章 总则 第一条 为进一步建立健全中化装备科技（青岛）股份有限公司（以下简 称公司）董事、高级管理人员的薪酬与考核管理制度，完善公司治理结构，根据 《中华人民共和国公司法》《上市公司治理准则》《上市公司独立董事管理办法》 《上海证券交易所股票上市规则》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等有关法律、行政法规、部门规章和规范性文件（以下统称法 律法规）以及 ...

中化装备科技(青岛)股份有限公司 年报信息披露重大差错责任追究制度 目 录 第一章 总则 第一条 为提高中化装备科技(青岛)股份有限公司(以下简称公司)的规范运 作水平，加大对年报信息披露责任人的问责力度，提高年报信息披露的质量和透 明度，增强年报信息披露的真实性、准确性、完整性和及时性，根据《中华人民 共和国公司法》《中华人民共和国证券法》《中华人民共和国会计法》《企业会 计准则》《上市公司信息披露管理办法》《上市公司治理准则》《上海证券交易 所股票上市规则》等法律、行政法规、部门规章、规范性文件（以下统称法律法 规）及《中化装备科技(青岛)股份有限公司章程》(以下简称《公司章程》)等规 定，结合公司实际情况，制订本制度。 第二条 本制度所指责任追究制度是指年报信息披露工作中有关人员不履行 或者不正确履行职责、义务或其他过错导致年报信息披露延迟、内容存在重大差 错或重大遗漏，对公司造成重大经济损失或造成不良社会影响时的追究与处理制 度。 第三条 本制度适用于公司董事、高级管理人员、各子公司负责人、控股股 东、实际控制人以及与年报信息披露工作有关的其他人员。 第四条 实行责任追究制度应遵循实事求是、客观公正、 ...

Financial Performance - The company reported a net profit attributable to shareholders of the parent company of -2,201,510,581.63 yuan for the year 2024[6]. - The beginning distributable profit for the parent company was -3,832,201,775.65 yuan, and the ending distributable profit was -4,717,970,237.76 yuan[6]. - The board of directors proposed not to distribute cash dividends or bonus shares for the year 2024 due to negative retained earnings[6]. - The company's operating revenue for 2024 was approximately ¥9.61 billion, a decrease of 17.18% compared to ¥11.61 billion in 2023[23]. - The net profit attributable to shareholders was approximately -¥2.20 billion, an improvement from -¥2.77 billion in the previous year[23]. - The net cash flow from operating activities was ¥241.47 million, a significant recovery from -¥885.15 million in 2023[23]. - The total assets decreased by 80.63% to approximately ¥3.78 billion from ¥19.51 billion in 2023[23]. - The basic earnings per share for 2024 was -¥4.44, an improvement from -¥5.56 in 2023[24]. - The weighted average return on equity increased to 572.73% from -131.45% in the previous year, primarily due to negative net profit calculations[24]. - The gross profit margin increased by 5.77 percentage points compared to the previous year, reaching 21.07%[58]. Risk Management - The company has not identified any significant risks that would materially affect its production and operations during the reporting period[8]. - The company emphasizes the importance of understanding the risks associated with forward-looking statements made in the report[7]. - The company faces macroeconomic risks, including geopolitical conflicts and global economic slowdown, which could impact demand for its products[95]. Corporate Governance - The company is under the supervision of the China Securities Regulatory Commission and the Shanghai Stock Exchange[13]. - The audit report issued by the accounting firm was a standard unqualified opinion[5]. - The company has established a robust internal control system, continuously improving governance mechanisms to align with regulatory standards[102]. - The company aims to improve compliance and internal control management to mitigate operational risks and enhance financial performance[90]. - The company has committed to avoiding competition with its controlling shareholder and related parties, as outlined in the commitments made by China National Chemical Corporation and its affiliates[103]. Asset Management - The company underwent a major asset restructuring, changing its subsidiary status for a significant asset, impacting financial reporting[25]. - The company reported a significant asset impairment provision in the third and fourth quarters, leading to a substantial decline in net profit[29]. - The company underwent a major asset restructuring, resulting in a significant change in the asset and liability situation, with the subsidiary no longer included in the consolidated financial statements[72]. - The company has engaged in significant asset restructuring involving a total debt of EUR 47,777.22 million[174]. Research and Development - Total R&D investment amounted to ¥374,739,538.17, representing 3.90% of operating revenue[64]. - The company employed 510 R&D personnel, making up 9.65% of the total workforce[65]. - Key projects include the development of plastic recycling technologies aimed at enhancing production efficiency and sustainability[67]. - The company is advancing the ColorForm in-mold painting technology to provide integrated production solutions for the automotive industry[67]. - The company plans to enhance its technological capabilities in key areas such as large drying equipment, anode protection devices, and industrial furnaces, focusing on domestic innovation and core technology independence[88]. Market Position and Strategy - The company operates in the high-end equipment manufacturing sector, focusing on plastic machinery, chemical equipment, and rubber machinery, which are key strategic emerging industries supported by the state[40]. - The company plans to optimize its layout and deepen market development in new materials and new energy sectors to achieve breakthroughs[77]. - The company is committed to deepening reforms and leveraging domestic equipment renewal strategies to seize new international market opportunities[90]. - The company is considering strategic acquisitions to bolster its product portfolio, with a budget of $100 million allocated for potential deals[111]. Shareholder Relations - The company plans to implement a three-year shareholder return plan from 2024 to 2026, aiming to enhance shareholder value[106]. - The board of directors has approved a share buyback program worth $150 million to enhance shareholder value[111]. - The company has committed to repurchasing shares with cash not less than 10% of the net profit achieved in the current year[154]. Environmental Commitment - The company aims for carbon neutrality by 2030, with a commitment to reducing plastic waste through advanced recycling technologies[147]. - The company invested CNY 12.69 million in environmental protection during the reporting period[143]. - The company has received recognition as a "waste-free enterprise" from local environmental authorities, reflecting its commitment to sustainable practices[148]. Legal Matters - The company is currently involved in multiple lawsuits with total claims amounting to 39.62 million yuan, including a claim of 23.96 million yuan for unpaid equipment[167]. - The company has filed for enforcement of a judgment in a case where it was awarded 22.16 million yuan[167]. - The company has not faced any legal violations or penalties during the reporting period[171]. Employee and Management Structure - The company has a total of 5,284 employees, with 2,637 in production, 1,219 in sales, and 766 in technical roles[132]. - The company has a diverse management team with extensive experience in various sectors, including oil and gas, finance, and corporate governance[110]. - The average age of the current board members is approximately 50 years, indicating a blend of experience and youthful leadership[108].

Financial Performance - The company's operating revenue for Q1 2025 was ¥224,042,058.35, a decrease of 90.18% compared to the same period last year[4]. - The net profit attributable to shareholders was -¥24,368,155.71, representing a decline of 164.85% year-on-year[4]. - Basic and diluted earnings per share were both -¥0.05, a decrease of 162.50% compared to the same period last year[4]. - The total comprehensive income for Q1 2025 was a loss of ¥10,933,741.79, compared to a loss of ¥133,273,150.40 in Q1 2024, showing an improvement of about 91.8%[18]. - The net profit for Q1 2025 was a loss of ¥24,368,155.71, compared to a net profit of ¥62,363,908.32 in Q1 2024, marking a year-over-year decline of 139.1%[18]. Cash Flow and Assets - The net cash flow from operating activities was ¥35,356,293.27, down 33.05% from the previous year[4]. - Cash flow from operating activities for Q1 2025 was ¥35,356,293.27, down from ¥52,813,816.63 in Q1 2024, reflecting a decrease of approximately 33.0%[21]. - Cash and cash equivalents at the end of Q1 2025 totaled ¥308,975,843.87, compared to ¥800,595,222.21 at the end of Q1 2024, a decline of about 61.4%[22]. - Total current assets increased to approximately 2.72 billion yuan as of March 31, 2025, compared to 2.57 billion yuan at the end of 2024, reflecting a growth of about 6%[12]. - The company's total liabilities increased to approximately 2.25 billion yuan, compared to 2.10 billion yuan at the end of 2024, indicating a rise of about 7%[14]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 40,787[8]. - The largest shareholder, China Chemical Science Institute Co., Ltd., held 43.40% of the shares[8]. Business Operations - The significant decline in revenue and profit was attributed to the restructuring of major assets and the change in the status of a subsidiary from a wholly-owned to an equity investment[4][6]. - The chemical machinery equipment business signed new orders of 408 million yuan in Q1, representing a year-on-year increase of 43%[10]. - The backlog of orders in the chemical machinery equipment sector reached 1.39 billion yuan, up 9.37% year-on-year[10]. - The rubber machinery equipment business maintained new orders at 26.79 million yuan, unchanged from the previous year, with a current backlog of 33.3 million yuan[10]. - The company aims to enhance sales and operational excellence, focusing on cost reduction and efficiency improvements despite a decline in new orders[11]. - The company reported a decrease in revenue due to a decline in new orders, but operational performance improved through cost-cutting measures[11]. Research and Development - The company reported a significant increase in research and development expenses, which were ¥22,383,086.90 in Q1 2025, compared to ¥91,068,796.56 in Q1 2024, indicating a reduction of approximately 75.5%[17]. Government Support - The government has allocated 300 billion yuan in special bonds to support the upgrade of consumer goods and equipment, creating new business opportunities in the industry[10].

中化装备科技（青岛）股份有限公司关于为公司 及董事、高级管理人员购买责任保险的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 中化装备科技（青岛）股份有限公司（以下简称"公司"）为进一步完善风 险管理体系、降低运营风险、促进董事、高管人员充分履职行权尽责，根据《中 华人民共和国公司法》《上市公司治理准则》等规定，于 2025 年 4 月 29 日召开 第八届董事会第十七次会议，审议了《关于为公司及董事、高级管理人员购买责 任保险的议案》。全体董事对该议案回避表决，该议案将直接提交公司股东会审 议。 一、责任险具体方案 证券代码：600579 证券简称：中化装备 编号：2025-019 （四）保险费预算：不超过 65 万元/年（具体以保险合同为准） （五）保险期限：12 个月，年度保险期满可续保或者重新投保 为提高决策效率，公司董事会提请公司股东会在上述权限内授权经营管理层 办理责任保险购买的相关事宜，包括但不限于确定其他相关个人主体；确定保险 公司；如市场发生变化，则根据市场情况确定责任限额、保险费总额及其他保险 条款； ...

中化装备科技（青岛）股份有限公司 独立董事独立性自查情况的专项报告 根据《上市公司独立董事管理办法》《上海证券交易所 上市公司自律监管指引第 1 号—规范运作》的规定，董事会 就公司在任独立董事刘雪娇女士、马战坤先生、孙凌玉女士 的独立性情况进行评估并出具如下专项意见： 二、董事会对独立董事独立性情况的评估意见 经公司独立董事刘雪娇女士、马战坤先生、孙凌玉女士自查 并结合其在公司的履职情况，董事会认为公司独立董事均能 够胜任独立董事的职责要求，其未在公司担任除独立董事以 外的任何职务，也未在公司主要股东公司担任任何职务，与 公司以及主要股东之间不存在妨碍其进行独立客观判断的 关系，不存在影响独立董事独立性的情况，符合《上市公司 独立董事管理办法》等法律法规及《公司章程》中关于独立 董事的任职资格及独立性的相关要求。 中化装备科技（青岛）股份有限公司董事会 2025 年 4 月 29 日 一、独立董事独立性自查情况 根据《上市公司独立董事管理办法》相关规定，公司独 立董事对自身的独立性情况进行了自查，并将自查情况提交 了董事会。自查结果显示，公司独立董事均符合《上市公司 独立董事管理办法》第六条的独立性要求，与 ...